Christopher M. Stauch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Christopher M. Stauch has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Michael Aynardi
Penn State College of Medicine, Hershey, PA, USA
5 shared publications - Brandon J. Martinazzi
Rothman Orthopaedic Institute, Thomas Jefferson University, Philadelphia, PA, USA
4 shared publications Anna Ptasinski
Penn State College of Medicine, The Pennsylvania State University, Hershey, PA, USA
3 shared publications- Kempland Corbin Walley
Department of Orthopaedic Surgery, Baylor University Medical Center, and Orthopedic Associates of Dallas
3 shared publications - Zachary Koroneos
Penn State College of Medicine Department of Orthopaedics and Rehabilitation The Pennsylvania State University Hershey Pennsylvania USA
3 shared publications Gregory J. Kirchner
Department of Orthopaedics and Rehabilitation, Penn State Health, Milton S. Hershey Medical Center, Hershey, PA, USA
2 shared publications
Latest Publications
- 7 November 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (6) , 1228-1234
Venous thromboembolism prophylaxis in shoulder surgery: a break-even cost-effectiveness study
- 7 November 2023
- Published by Elsevier in Journal of Shoulder and Elbow Surgery
- Vol. 33 (6) , 1228-1234
Venous thromboembolism prophylaxis in shoulder surgery: a break-even cost-effectiveness study
- Open Access
- 11 October 2023
- Published by SAGE Publications in Foot & Ankle International
- Vol. 44 (12) , 1278-1286
Establishment of a Neurodegenerative Charcot Mouse Model
Background: This study aimed to mimic the changes from Charcot neuropathic arthropathy in humans by examining the effects of exposing diet-induced obese (DIO) mice to neurotrauma through a regimented running protocol. Methods: Forty-eight male wild-type C57BL/6J mice were obtained at age 6 weeks and separated into 2 groups for diet assignment. After a 1-week acclimation period, half of the mice consumed a high-fat diet (60% fat by kcal) ad libitum to facilitate neuropathic diet-induced obesity whereas the other half were control mice and consumed an age-matched standard low-fat control diet (10% fat by kcal). At age 12 weeks, half of the animals from each group were subjected to a high-intensity inclined treadmill running protocol, which has been previously demonstrated to induce neurotrauma. Sensory testing and radiographic analyses were periodically performed. Histopathologic analyses were performed post killing. Results: DIO mice had significantly higher bodyweights, higher body fat percentages, and lower bone mineral density than wildtype control mice that were fed a normal diet throughout the experiment ( P < .001 for each). DIO mice displayed significantly reduced sensory function in week 1 ( P = .005) and this worsened over time, requiring 20.6% more force for paw withdrawal by week 10 ( P < .001). DIO mice that ran demonstrated greater midfoot subluxation and tarsal instability over all time points compared with normal-diet mice that ran ( P < .001). Histopathologic analyses revealed that DIO mice that ran demonstrated significant changes compared with controls that ran ( P < .001 for each parameter). Conclusion: Changes akin to the earliest changes observed in or before joint destruction identified in diabetic Charcot neuropathic arthropathy in humans were observed. Clinical Relevance: There is currently no standard of treatment for patients with Charcot neuropathic arthropathy. This study establishes a protocol for an animal model that can be used to study and compare interventions to treat this disease.
- 11 October 2023
- Published by SAGE Publications in Foot & Ankle International
- Vol. 44 (12) , 1278-1286
Open AccessEstablishment of a Neurodegenerative Charcot Mouse Model
Background: This study aimed to mimic the changes from Charcot neuropathic arthropathy in humans by examining the effects of exposing diet-induced obese (DIO) mice to neurotrauma through a regimented running protocol. Methods: Forty-eight male wild-type C57BL/6J mice were obtained at age 6 weeks and separated into 2 groups for diet assignment. After a 1-week acclimation period, half of the mice consumed a high-fat diet (60% fat by kcal) ad libitum to facilitate neuropathic diet-induced obesity whereas the other half were control mice and consumed an age-matched standard low-fat control diet (10% fat by kcal). At age 12 weeks, half of the animals from each group were subjected to a high-intensity inclined treadmill running protocol, which has been previously demonstrated to induce neurotrauma. Sensory testing and radiographic analyses were periodically performed. Histopathologic analyses were performed post killing. Results: DIO mice had significantly higher bodyweights, higher body fat percentages, and lower bone mineral density than wildtype control mice that were fed a normal diet throughout the experiment ( P < .001 for each). DIO mice displayed significantly reduced sensory function in week 1 ( P = .005) and this worsened over time, requiring 20.6% more force for paw withdrawal by week 10 ( P < .001). DIO mice that ran demonstrated greater midfoot subluxation and tarsal instability over all time points compared with normal-diet mice that ran ( P < .001). Histopathologic analyses revealed that DIO mice that ran demonstrated significant changes compared with controls that ran ( P < .001 for each parameter). Conclusion: Changes akin to the earliest changes observed in or before joint destruction identified in diabetic Charcot neuropathic arthropathy in humans were observed. Clinical Relevance: There is currently no standard of treatment for patients with Charcot neuropathic arthropathy. This study establishes a protocol for an animal model that can be used to study and compare interventions to treat this disease.
- Open Access
- 15 November 2022
- Published by SAGE Publications in Foot & Ankle Orthopaedics
- Vol. 7 (4)
Can Sociodemographic Factors be Used to Help Predict Outcomes in Charcot Neuroarthropathy?
Category: Diabetes; Other Introduction/Purpose: The diabetic Charcot foot, or Charcot neuroarthropathy, is a devastating condition that arises secondary to longstanding diabetes, peripheral neuropathy, and trauma. One of the many challenges associated with the Charcot patient is the lack of data exploring factors that may predict long-term outcomes. Therefore, the purpose of this study was to evaluate how certain sociodemographic factors may influence mortality and the need to undergo lower extremity amputation in patients with Charcot. Methods: Following institutional board approval, all patients from 2015-2021 with a diagnosis of Charcot Foot were queried using hospital electronic medical records. Demographics collected included sex, age, race, and insurance coverage. Outcomes recorded were the need to undergo major amputation and mortality rate. Statistical analysis was then run to determine if sex, age, race, and insurance coverage was associated with increased risk of needing a major amputation or death. Results: From 2015-2021, 80 Charcot patients with a mean age of 60 (Range, 84-32) were identified. Of these patients, 58 were male, 26 were female, 71 were white, 3 were African American, and 6 were identified as other. In our cohort, 47 patients had government funded insurance and 33 had private insurance. Amputation occurred in 22 patients and death in 15. Government funded insurance (RR: 9.8, 95% CI:1.4-71.1, P = 0.0236) and age over 65 was associated with an increased risk of death (RR: 2.5, 95% CI: 1.02 to 6.17; P = 0.044). No statistically significant increased risk of death or amputation was found in white, African American, male, or female patients. Government insurance was also not associated with an increased risk for amputation (Table 1). Conclusion: Charcot Neuroarthropathy is associated with high rates of morbidity and mortality. In our cohort, there was an increased risk of mortality in patients with government funded insurance and patients over the age of 65. Further investigation exploring the role of sociodemographic factors is warranted.
- 15 November 2022
- Published by SAGE Publications in Foot & Ankle Orthopaedics
- Vol. 7 (4)
Open AccessCan Sociodemographic Factors be Used to Help Predict Outcomes in Charcot Neuroarthropathy?
Category: Diabetes; Other Introduction/Purpose: The diabetic Charcot foot, or Charcot neuroarthropathy, is a devastating condition that arises secondary to longstanding diabetes, peripheral neuropathy, and trauma. One of the many challenges associated with the Charcot patient is the lack of data exploring factors that may predict long-term outcomes. Therefore, the purpose of this study was to evaluate how certain sociodemographic factors may influence mortality and the need to undergo lower extremity amputation in patients with Charcot. Methods: Following institutional board approval, all patients from 2015-2021 with a diagnosis of Charcot Foot were queried using hospital electronic medical records. Demographics collected included sex, age, race, and insurance coverage. Outcomes recorded were the need to undergo major amputation and mortality rate. Statistical analysis was then run to determine if sex, age, race, and insurance coverage was associated with increased risk of needing a major amputation or death. Results: From 2015-2021, 80 Charcot patients with a mean age of 60 (Range, 84-32) were identified. Of these patients, 58 were male, 26 were female, 71 were white, 3 were African American, and 6 were identified as other. In our cohort, 47 patients had government funded insurance and 33 had private insurance. Amputation occurred in 22 patients and death in 15. Government funded insurance (RR: 9.8, 95% CI:1.4-71.1, P = 0.0236) and age over 65 was associated with an increased risk of death (RR: 2.5, 95% CI: 1.02 to 6.17; P = 0.044). No statistically significant increased risk of death or amputation was found in white, African American, male, or female patients. Government insurance was also not associated with an increased risk for amputation (Table 1). Conclusion: Charcot Neuroarthropathy is associated with high rates of morbidity and mortality. In our cohort, there was an increased risk of mortality in patients with government funded insurance and patients over the age of 65. Further investigation exploring the role of sociodemographic factors is warranted.
- Open Access
- 15 November 2022
- Published by SAGE Publications in Foot & Ankle Orthopaedics
- Vol. 7 (4)
3-T MRI Outperforms 1.5-T MRI in Diagnosis of Osteochondral Lesions of the Talus in Patients Undergoing Broström Repair
Category: Ankle; Arthroscopy Introduction/Purpose: Osteochondral lesions of the talus (OLT) are commonly seen in patients with lateral ankle instability. If left undiagnosed, OLTs can cause significant ankle pain, progressive osteoarthritis, and contribute to increased morbidity after an ankle sprain. Arthroscopy has long been the gold standard for OLT diagnosis. While MRI is a useful imaging modality for pre- operative evaluation and planning, prior research on the diagnostic utility of pre-operative MRI for OLTs observes low detection rates. With 3-T scanners replacing 1.5-T scanners, long considered the clinical standard, there is potential that 3-T MRIs may improve MRI's diagnostic efficacy. The purpose of this study is to assess the efficacy of 3-T MRI and 1.5-T MRI in diagnosing OLTs in patients undergoing Broström Gould procedure for lateral ankle instability. Methods: Following institutional review board approval, a database was obtained for all patients from 2/11/2015 to 1/21/2019 who underwent a Broström Gould procedure for lateral ankle instability in addition to diagnostic arthroscopy of the tibiotalar joint. Additionally, patients required a pre-operative MRI for inclusion in the study. Patients who underwent the Broström Gould procedure, but did not have a diagnostic arthroscopy or did not have a pre-operative MRI were excluded from the study. Patient charts were then reviewed to determine the field strength of the preoperative MRIs, and the efficacy of 3-T MRIs and 1.5-T MRIs in correctly identifying the presence or absence of OLTs using diagnostic arthroscopy as a reference standard. Patients with pre- operative MRIs where the field strength was either unlabeled or could not be determined, as they were conducted at outside institutions, were excluded from analysis. Results: Forty (49.4%) out of 81 patients were identified of having preoperative MRI with identifiable field strength, Broström Gould procedure for lateral ankle instability, and diagnostic arthroscopy of the tibiotalar joint. The average age was 37.3 +- 14.2 years. Twenty-four (60.0%) patients were female and 16 (40.0%) were male. Nineteen (47.5%) patients had OLTs identified via diagnostic arthroscopy. Twenty-one patients had a preoperative 3-T MRI, and 19 patients had a preoperative 1.5-T MRI (Table 1). The sensitivity and specificity of 3-T MRI was 75% and 100%; the sensitivity and specificity of 1.5-T M was 72.7% and 87.5%, respectively. For 3-T MRI, six patients were correctly identified as having OLTs, and 13 patients were correctly identified as not having OLTs. For 1.5-T MRI, eight patients were correctly identified as having OLTs, and seven patients were correctly identified as not having OLTs. Conclusion: Three-Tesla MRI appears to be superior to 1.5-T MRI in diagnosing OLTs in patients undergoing Broström Gould procedure for lateral ankle instability. Three-Tesla MRI demonstrates a sensitivity and specificity of 75.0% and 100%, respectively, whereas 1.5-T MRI is associated with a sensitivity and specificity of 72.7% and 87.5%. Three-Tesla MRI's low false positive rate provides support for the efficacy of this imaging modality to rule in OLTs and prompt arthroscopic surgery with subsequent OLT treatment. This suggests that 3-T MRIs may prove useful in clinical decision making regarding OLTs in patients undergoing Broström Gould procedure for lateral ankle instability.
- 15 November 2022
- Published by SAGE Publications in Foot & Ankle Orthopaedics
- Vol. 7 (4)
Open Access3-T MRI Outperforms 1.5-T MRI in Diagnosis of Osteochondral Lesions of the Talus in Patients Undergoing Broström Repair
Category: Ankle; Arthroscopy Introduction/Purpose: Osteochondral lesions of the talus (OLT) are commonly seen in patients with lateral ankle instability. If left undiagnosed, OLTs can cause significant ankle pain, progressive osteoarthritis, and contribute to increased morbidity after an ankle sprain. Arthroscopy has long been the gold standard for OLT diagnosis. While MRI is a useful imaging modality for pre- operative evaluation and planning, prior research on the diagnostic utility of pre-operative MRI for OLTs observes low detection rates. With 3-T scanners replacing 1.5-T scanners, long considered the clinical standard, there is potential that 3-T MRIs may improve MRI's diagnostic efficacy. The purpose of this study is to assess the efficacy of 3-T MRI and 1.5-T MRI in diagnosing OLTs in patients undergoing Broström Gould procedure for lateral ankle instability. Methods: Following institutional review board approval, a database was obtained for all patients from 2/11/2015 to 1/21/2019 who underwent a Broström Gould procedure for lateral ankle instability in addition to diagnostic arthroscopy of the tibiotalar joint. Additionally, patients required a pre-operative MRI for inclusion in the study. Patients who underwent the Broström Gould procedure, but did not have a diagnostic arthroscopy or did not have a pre-operative MRI were excluded from the study. Patient charts were then reviewed to determine the field strength of the preoperative MRIs, and the efficacy of 3-T MRIs and 1.5-T MRIs in correctly identifying the presence or absence of OLTs using diagnostic arthroscopy as a reference standard. Patients with pre- operative MRIs where the field strength was either unlabeled or could not be determined, as they were conducted at outside institutions, were excluded from analysis. Results: Forty (49.4%) out of 81 patients were identified of having preoperative MRI with identifiable field strength, Broström Gould procedure for lateral ankle instability, and diagnostic arthroscopy of the tibiotalar joint. The average age was 37.3 +- 14.2 years. Twenty-four (60.0%) patients were female and 16 (40.0%) were male. Nineteen (47.5%) patients had OLTs identified via diagnostic arthroscopy. Twenty-one patients had a preoperative 3-T MRI, and 19 patients had a preoperative 1.5-T MRI (Table 1). The sensitivity and specificity of 3-T MRI was 75% and 100%; the sensitivity and specificity of 1.5-T M was 72.7% and 87.5%, respectively. For 3-T MRI, six patients were correctly identified as having OLTs, and 13 patients were correctly identified as not having OLTs. For 1.5-T MRI, eight patients were correctly identified as having OLTs, and seven patients were correctly identified as not having OLTs. Conclusion: Three-Tesla MRI appears to be superior to 1.5-T MRI in diagnosing OLTs in patients undergoing Broström Gould procedure for lateral ankle instability. Three-Tesla MRI demonstrates a sensitivity and specificity of 75.0% and 100%, respectively, whereas 1.5-T MRI is associated with a sensitivity and specificity of 72.7% and 87.5%. Three-Tesla MRI's low false positive rate provides support for the efficacy of this imaging modality to rule in OLTs and prompt arthroscopic surgery with subsequent OLT treatment. This suggests that 3-T MRIs may prove useful in clinical decision making regarding OLTs in patients undergoing Broström Gould procedure for lateral ankle instability.
- Open Access
- 28 July 2022
- Published by SAGE Publications in Foot & Ankle International
- Vol. 43 (10) , 1379-1384
Cost-Effective Modeling of Thromboembolic Chemoprophylaxis for Total Ankle Arthroplasty
Background: Symptomatic venous thromboembolism (VTE) following total ankle arthroplasty (TAA) can cause substantial morbidity and mortality. To prevent this complication, surgeons often prescribe postoperative chemoprophylaxis. However, much controversy exists regarding the efficacy of chemoprophylaxis because of the limited studies exploring its use. Furthermore, even less is known about its cost-effectiveness. Therefore, this study sought to determine the cost-effectiveness of commonly prescribed chemoprophylactic agents using a break-even analysis economic model. Methods: The literature was searched, and an online database was used to identify patients who developed a symptomatic VTE after undergoing TAA. Our institutional records were used to estimate the cost of treating a symptomatic VTE, and an online drug database was used to obtain the cost of commonly prescribed chemoprophylactic agents. A break-even analysis was then performed to determine the final break-even rate necessary to make a drug cost-effective. Results: The low and high rates of symptomatic VTE were determined to be 0.46% and 9.8%. From 2011 to 2021, a total of 3455 patients underwent total ankle arthroplasty. Of these patients, 16 developed a postoperative symptomatic VTE (1.01%). Aspirin 81 mg was cost-effective if the initial symptomatic VTE rates decreased by an absolute risk reduction (ARR) of 0.0003% (NNT = 31 357). Aspirin 325 mg was also cost-effective if the initial rates decreased by an ARR 0.02% (NNT = 5807). Likewise, warfarin (5 mg) was cost-effective at all initial rates with an ARR of 0.02% (NNT = 4480). In contrast, enoxaparin (40 mg) and rivaroxaban (20 mg) were only cost-effective at higher initial symptomatic VTE rates with ARRs of 1.48% (NNT = 68) and 5.36% (NNT = 19). Additional analyses demonstrated that enoxaparin (40 mg) and rivaroxaban (20 mg) become cost-effective when costs of treating a symptomatic VTE are higher than our estimates. Conclusion: Chemoprophylaxis following TAA can be cost-effective. A tailored approach to VTE prophylaxis with cost-effectiveness in mind may be beneficial to the patient and health system.
- 28 July 2022
- Published by SAGE Publications in Foot & Ankle International
- Vol. 43 (10) , 1379-1384
Open AccessCost-Effective Modeling of Thromboembolic Chemoprophylaxis for Total Ankle Arthroplasty
Background: Symptomatic venous thromboembolism (VTE) following total ankle arthroplasty (TAA) can cause substantial morbidity and mortality. To prevent this complication, surgeons often prescribe postoperative chemoprophylaxis. However, much controversy exists regarding the efficacy of chemoprophylaxis because of the limited studies exploring its use. Furthermore, even less is known about its cost-effectiveness. Therefore, this study sought to determine the cost-effectiveness of commonly prescribed chemoprophylactic agents using a break-even analysis economic model. Methods: The literature was searched, and an online database was used to identify patients who developed a symptomatic VTE after undergoing TAA. Our institutional records were used to estimate the cost of treating a symptomatic VTE, and an online drug database was used to obtain the cost of commonly prescribed chemoprophylactic agents. A break-even analysis was then performed to determine the final break-even rate necessary to make a drug cost-effective. Results: The low and high rates of symptomatic VTE were determined to be 0.46% and 9.8%. From 2011 to 2021, a total of 3455 patients underwent total ankle arthroplasty. Of these patients, 16 developed a postoperative symptomatic VTE (1.01%). Aspirin 81 mg was cost-effective if the initial symptomatic VTE rates decreased by an absolute risk reduction (ARR) of 0.0003% (NNT = 31 357). Aspirin 325 mg was also cost-effective if the initial rates decreased by an ARR 0.02% (NNT = 5807). Likewise, warfarin (5 mg) was cost-effective at all initial rates with an ARR of 0.02% (NNT = 4480). In contrast, enoxaparin (40 mg) and rivaroxaban (20 mg) were only cost-effective at higher initial symptomatic VTE rates with ARRs of 1.48% (NNT = 68) and 5.36% (NNT = 19). Additional analyses demonstrated that enoxaparin (40 mg) and rivaroxaban (20 mg) become cost-effective when costs of treating a symptomatic VTE are higher than our estimates. Conclusion: Chemoprophylaxis following TAA can be cost-effective. A tailored approach to VTE prophylaxis with cost-effectiveness in mind may be beneficial to the patient and health system.
- 1 August 2020
- Published by Elsevier in Foot and Ankle Surgery
- Vol. 26 (6) , 708-711
Prognostic risk factors for complications associated with tibiotalocalcaneal arthrodesis with a nail
- 1 August 2020
- Published by Elsevier in Foot and Ankle Surgery
- Vol. 26 (6) , 708-711
Prognostic risk factors for complications associated with tibiotalocalcaneal arthrodesis with a nail
- 3 June 2020
- Published by SAGE Publications in Foot & Ankle Specialist
- Vol. 14 (6) , 501-508
Comparing the Efficacy of True-Volume Analysis Using Magnetic Resonance Imaging With Computerized Tomography and Conventional Methods of Evaluation in Cystic Osteochondral Lesions of the Talus: A Pilot Study
Background: Osteochondral lesions of the talus (OLT) often require advanced imaging if they prove to be refractory to preliminary microfracture. Orthopedic surgeons may misinterpret the size and morphology of the OLT when evaluating through conventional methods. The purpose of this study was to evaluate MRI as a modality for calculating true-volumes and compare its utility to that of CT true-volume and conventional methods of measuring lesion size. Methods: With IRB approval, an institutional radiology database was queried for patients with cystic OLT that had undergone and failed microfracture and had compatible CT and MR scans between 2011 and 2016. Five lesions, previously analyzed and described in the literature using CT true-volume, were selected. 10 orthopedic surgeons independently estimated the volume of these 5 OLT via standard MRI. Next, 3D reconstructions were created and morphometric true-volume (MTV) analysis measurements of each OLT were generated. The percent change in volumes from CT and MR was compared based upon MTVs determined from 3D reconstructive analysis. Results: The volume calculated using conventional methods in CT and MR scans grossly overestimated the size by of the OLT by 285-864% and 56-374% respectively when compared to 3D true-volume analysis of those CT and MR scans. Conclusions: This study demonstrates that true-volume is more accurate for calculating lesion size than conventional methods. Additionally, when comparing MRI and CT, thin slice CT true-volume is superior to MRI true-volume. True-volume calculation improves accuracy with CT and MRI and should be recommended for use in revision OLT cases. Levels of Evidence: Level III: Case control study
- 3 June 2020
- Published by SAGE Publications in Foot & Ankle Specialist
- Vol. 14 (6) , 501-508
Comparing the Efficacy of True-Volume Analysis Using Magnetic Resonance Imaging With Computerized Tomography and Conventional Methods of Evaluation in Cystic Osteochondral Lesions of the Talus: A Pilot Study
Background: Osteochondral lesions of the talus (OLT) often require advanced imaging if they prove to be refractory to preliminary microfracture. Orthopedic surgeons may misinterpret the size and morphology of the OLT when evaluating through conventional methods. The purpose of this study was to evaluate MRI as a modality for calculating true-volumes and compare its utility to that of CT true-volume and conventional methods of measuring lesion size. Methods: With IRB approval, an institutional radiology database was queried for patients with cystic OLT that had undergone and failed microfracture and had compatible CT and MR scans between 2011 and 2016. Five lesions, previously analyzed and described in the literature using CT true-volume, were selected. 10 orthopedic surgeons independently estimated the volume of these 5 OLT via standard MRI. Next, 3D reconstructions were created and morphometric true-volume (MTV) analysis measurements of each OLT were generated. The percent change in volumes from CT and MR was compared based upon MTVs determined from 3D reconstructive analysis. Results: The volume calculated using conventional methods in CT and MR scans grossly overestimated the size by of the OLT by 285-864% and 56-374% respectively when compared to 3D true-volume analysis of those CT and MR scans. Conclusions: This study demonstrates that true-volume is more accurate for calculating lesion size than conventional methods. Additionally, when comparing MRI and CT, thin slice CT true-volume is superior to MRI true-volume. True-volume calculation improves accuracy with CT and MRI and should be recommended for use in revision OLT cases. Levels of Evidence: Level III: Case control study